| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| thioredoxin reductase | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| TDP1 protein | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 6 | 0 | 0 | 6 |
| Bloom syndrome protein isoform 1 | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 3 | 0 | 6 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 1 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 3 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
| Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
| Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
| RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 1 | 0 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 1 | 0 | 0 | 1 |
| GLI family zinc finger 3 | 3 | 0 | 0 | 3 |
| AR protein | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
| progesterone receptor | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 4 | 0 | 0 | 4 |
| retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
| farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
| pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
| estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
| G | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
| peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
| caspase-3 | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
| Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
| Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 9 | 0 | 9 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Interferon beta | 3 | 0 | 0 | 3 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
| Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 3 |
| Glutamate receptor 2 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 2 |
| Acetylcholinesterase | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 3 | 0 | 3 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Microsomal triglyceride transfer protein large subunit | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 0 | 2 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 0 | 1 | 0 | 1 |
| Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 2 | 1 | 8 |
| Protease | 0 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 6 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Ataxin-2 | 3 | 0 | 0 | 3 |
| Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Reverse transcriptase | 0 | 1 | 1 | 2 |
| Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 1 | 0 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| geminin | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 2 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| ClpP | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Aromatase | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 1 | 8 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 4 | 2 | 6 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 2 | 2 | 4 |
| Melatonin receptor type 1B | 0 | 4 | 2 | 6 |
| Melatonin receptor type 1C | 0 | 2 | 2 | 4 |
| Melatonin receptor type 1B | 0 | 2 | 2 | 4 |
| Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
| Sodium-dependent serotonin transporter | 0 | 0 | 1 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 3 | 1 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Translocator protein | 0 | 1 | 1 | 2 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 2 |
| Delta-type opioid receptor | 0 | 2 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Mu-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 1 | 5 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Mu-type opioid receptor | 0 | 2 | 1 | 5 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| GLS protein | 2 | 0 | 0 | 2 |
| polyprotein | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 1 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 5 | 2 | 8 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 0 | 1 | 1 |
| Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
| Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 4 | 3 | 7 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 2 | 4 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 3 | 3 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 1 | 2 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 1 | 2 | 3 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1E | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 1 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| retinoid X nuclear receptor alpha | 1 | 0 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 1 | 0 | 0 | 1 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 2 | 2 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 1 | 0 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Substance-K receptor | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 1 | 3 |
| Neuromedin-K receptor | 0 | 1 | 1 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
| Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |